Summary:
Click image to enlargeLocal doctors are conducting a clinical trial to test the effectiveness of an investigational liver-selective glucokinase activator for management of Type 1 Diabetes.
Qualified Participants Must:
• Have been diagnosed with T1D
•
Be between the ages of 18-70 years
•
Have a BMI less than 35
•
Be a current insulin pump user with lispro or aspart
•
Have at least 2 months experience with Dexcom CGM (continuous glucose monitoring)
•
Own a mobile phone compatible to use Dexcom Clarity app
Qualified Participants May Receive:
Compensation may be given for time and travel to qualified participants.